Listen Now
Topics Covered
- Overview and Definition of Biosimilars
- The Difference Between Biosimilars and Generic Drugs
- How Biosimilars Work and Their Use
- Examples of Biosimilars
- Implications in Managing the Costs of Cancer Treatment
- Clinical Trials: How Biosimilar Research Contributes to Treatment Options
- The Benefits of Biosimilars
- Current Use in the Care of People Living with Cancer
- Key Questions to Ask Your Health Care Team About Biosimilars
- Current and Future Perspectives
- Questions for Our Panel of Experts
Our Panel of Experts

Richard J. Gralla, MD, FACP
Professor of Medicine, Albert Einstein College of Medicine, Jacobi Medical Center

Jeffrey Crawford, MD
George Barth Geller Professor for Research in Cancer, Department of Medicine, Duke University School of Medicine, Co-Director, Solid Tumor Therapeutics Program, Duke Cancer Institute

Lisa M. Thompson, PharmD, BCOP
Pharmacy Program Coordinator, PGY2 Oncology Residency Program Director, Banner MD Anderson Cancer Center

Caroline Edlund, MSW
Online Support Group Program Director, CancerCare
Brochure
You can download the brochure for this workshop(80.3 KB)
Workshop Date
This workshop was originally recorded on February 01, 2017.